Tag

Lixisenatide

All articles tagged with #lixisenatide

health1 year ago•4 min saved

"GLP-1 Diabetes Medication Shows Promise in Slowing Parkinson's Disease Progression"

In a Phase 2 clinical trial, the diabetes medication lixisenatide showed promise in slowing the progression of motor symptoms in people with Parkinson’s disease. While gastrointestinal side effects were more common with the therapy, the findings support lixisenatide as a potential treatment for Parkinson’s, with researchers calling for more studies to confirm its effects. The study's main goal was to assess the effect of treatment on the severity of motor symptoms, and results showed that lixisenatide modestly reduced motor disability progression in patients with early Parkinson’s disease compared with a placebo, but had gastrointestinal side effects.

via Parkinson's News Today|

#clinical-trial #diabetes-medication #health

health-medical-research1 year ago•2 min saved

"GLP-1 Diabetes Drug Slows Parkinson's Progression in Small Trial"

A small mid-stage trial has shown that the diabetes drug lixisenatide, similar to Ozempic, helped slow the progression of motor disability in patients with early-stage Parkinson's disease. The drug, made by Sanofi, demonstrated potential in mitigating symptoms such as tremors and stiffness, but was also associated with an increased risk of gastrointestinal side effects. Larger and longer studies are needed to fully determine the efficacy and safety of this treatment for Parkinson's disease.

via CNBC|

#diabetes-drug #health-medical-research #lixisenatide

health1 year ago•2 min saved

"GLP-1 Drug Shows Promise in Slowing Parkinson's Progression, Study Finds"

Researchers have found that a type 2 diabetes medication called lixisenatide may slow the progression of symptoms in Parkinson's disease, supporting the theory that Parkinson's could be associated with insulin resistance in the brain. In a study, participants given lixisenatide showed essentially no progression of motor problems, while those given a placebo showed worsening symptoms. However, some participants receiving lixisenatide reported nausea and vomiting. The findings pave the way for larger phase 3 clinical trials and suggest that GLP-1R agonists have potential for treating Parkinson's.

via The Guardian|

#diabetes-medication #disease-progression #health

health1 year ago•1 min saved

"Ozempic-Like Drug Shows Promise in Slowing Parkinson's Progression"

A small study has shown that Lixisenatide, a drug in the same class as Ozempic and Wegovy, may slow the progression of Parkinson's disease. This offers hope after decades of unsuccessful clinical trials for the degenerative brain illness, which affects as many as half a million Americans. The study, lasting one year, marks the first glimmer of success in slowing the disease, which is characterized by symptoms such as tremors, slowness, stiffness, and difficulty with balance.

via The New York Times|

#glp-1-drugs #health #lixisenatide